Simultaneously, oligomeric cystatin C binds to the inhibitory receptors LILRB2 and LILRB5 on myeloid cells, thereby increasing their immunosuppressive activity and contributing to tumor progression. This evidence concerns the gene LILRB2 and neoplasm.